Clinical Trial Update: The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer [Phase 2]

View source ↗

Summary

A Phase II trial (The Phoenix Trial) is evaluating cemiplimab for non-operative management of localized dMMR colon cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colon Cancer | Phase 2 | Status: RECRUITING